Investigating a universal vaccine for influenza
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
This study is looking at how the flu virus spreads and how our immune system responds to it, with the goal of helping create a better flu vaccine that works against many different strains, and it's for anyone interested in improving flu prevention and treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11196842 on NIH RePORTER |
What this research studies
This research focuses on understanding the factors that affect the evolution and transmission of influenza viruses, as well as the immune response to these infections. It involves cohort studies and sampling from both humans and animals to gather data on how influenza spreads and how effective vaccinations can be. By identifying the immunological factors that influence disease outcomes, the research aims to enhance the development of a universal influenza vaccine that could provide broader protection against various strains of the virus.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals who are at high risk for influenza, such as the elderly, young children, and those with compromised immune systems.
Not a fit: Patients who are not at risk for influenza or those who have already received effective vaccination may not receive significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a universal influenza vaccine, significantly reducing the incidence and severity of influenza infections.
How similar studies have performed: Previous research has shown promise in developing universal vaccines for influenza, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Garcia-Sastre, Adolfo — Icahn School of Medicine at Mount Sinai
- Study coordinator: Garcia-Sastre, Adolfo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.